Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Richard H. Parrish"'
Autor:
William Olin Blair, Mary Allison Ellis, Maria Fada, Austin Allen Wiggins, Rachel C. Wolfe, Gourang P. Patel, Kara K. Brockhaus, Molly Droege, Laura M. Ebbitt, Brian Kramer, Eric Likar, Kerilyn Petrucci, Sapna Shah, Jerusha Taylor, Paula Bingham, Samuel Krabacher, Jin Hyung Moon, Monica Rogoz, Edson Jean-Jacques, Robert K. Cleary, Ransome Eke, Rachelle Findley, Richard H. Parrish
Publikováno v:
Healthcare, Vol 11, Iss 23, p 3060 (2023)
Background: The application of enhanced recovery after surgery principles decreases postoperative complications (POCs), length of stay (LOS), and readmissions. Pharmacoprophylaxis decreases morbidity, but the effect of specific regimens on clinical o
Externí odkaz:
https://doaj.org/article/b9c7954de06b419fba768c848f8dd8c2
Autor:
Richard H. Parrish
Publikováno v:
Gastroenterology Insights, Vol 12, Iss 3, Pp 293-301 (2021)
This commentary summarizes a collection of key references published within the last ten years, and identifies pharmacologic research directions to improve treatment access and success through greater biosimilar or “follow-on” biologic utilization
Externí odkaz:
https://doaj.org/article/7898e819f73342c394982f631f6df08a
Publikováno v:
Children, Vol 9, Iss 12, p 1885 (2022)
Drugs administered to children in the United States fall into two broad categories: (1) those that have followed the US Food and Drug Administration (US-FDA) pediatric drug approval process and are marketed as finished dosage forms with pediatric lab
Externí odkaz:
https://doaj.org/article/ba0b4afefb5042dcbc257fc5867bf26c
Autor:
Richard H. Parrish, Scott Ciarkowski, David Aguero, Sandra Benavides, Donna Z. Bohannon, Roy Guharoy, on behalf of the United States Pharmacopeia Compounded Drug Preparation Information Exchange Expert Panel
Publikováno v:
Children, Vol 9, Iss 10, p 1493 (2022)
The perspectives of the Compounded Drug Preparation Information Exchange Expert Panel of the United States Pharmacopeia (CDPIE-EP) on the urgent need to create and maintain data standards to support the electronic transmission of an interoperable dat
Externí odkaz:
https://doaj.org/article/db502131f0ca4e92b9b3b40970e3d8cf
Autor:
Richard H. Parrish, Lisa D. Ashworth, Raimar Löbenberg, Sandra Benavides, Jeffrey J. Cies, Robert B. MacArthur
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 1032 (2022)
The purpose of this work was to evaluate the suitability of recent US Food and Drug Administration (US-FDA)-approved and marketed oral liquid, powder, or granule products for children in North America, to identify the next group of Active Pharmaceuti
Externí odkaz:
https://doaj.org/article/900e831085034434b695028b0eb10908
Autor:
Richard H. Parrish
Publikováno v:
Healthcare, Vol 9, Iss 6, p 687 (2021)
Cohn’s work fills a void in the perioperative care literature by providing a concise, comprehensive, practical, and authoritative guide to the medical management of common periprocedural issues and scenarios [...]
Externí odkaz:
https://doaj.org/article/de9cb7b1ad834c3890e41a640c198d6a
Autor:
Varsha Bhatt-Mehta, Robert B. MacArthur, Raimar Löbenberg, Jeffrey J. Cies, Ibolja Cernak, Richard H. Parrish
Publikováno v:
AAPS Open, Vol 2, Iss 1, Pp 1-8 (2016)
Abstract The gap in the commercially-available pediatric drug products and formulations suitable for children, especially those below the age of 6 years, is long recognized. A group of clinicians and scientists with a common interest in pediatric dru
Externí odkaz:
https://doaj.org/article/bbd598645334498ba8437383c75a3356
Autor:
Varsha Bhatt-Mehta, Robert B. MacArthur, Raimar Löbenberg, Jeffrey J. Cies, Ibolja Cernak, Richard H. Parrish II
Publikováno v:
Pharmacy, Vol 3, Iss 4, Pp 284-294 (2015)
The lack of commercially-available pediatric drug products and dosage forms is well-known. A group of clinicians and scientists with a common interest in pediatric drug development and medicines-use systems developed a practical framework for identif
Externí odkaz:
https://doaj.org/article/c8af00a48bc84f5591c448ac74837482
Autor:
Richard H. Parrish, Lucy Gilak, Donna Bohannon, Steven P. Emrick, Brian Serumaga, Roy Guharoy
Publikováno v:
Pharmacy, Vol 7, Iss 4, p 149 (2019)
Lack of standardization related to compounded drug preparations, especially in the transition of care situations, threatens patient safety by facilitating medication error. This paper outlines progress to-date from the United States Pharmacopeia (USP
Externí odkaz:
https://doaj.org/article/758ca01802de4910be2e0e0ab80a8196
Autor:
Richard H. Parrish II, Sandra Benavides, Joseph T. Malak, Amy L. Potts, Micheal Guirguis, Tracy Hagemann
Publikováno v:
Pharmacy, Vol 2, Iss 4, Pp 260-269 (2014)
A pediatric compounded non-sterile products repository (pCNP) to optimize the effectiveness and safety of “off-label” use of compounded pharmacotherapy through complete transmission of electronic prescriptions across the continuum of care is desc
Externí odkaz:
https://doaj.org/article/4b23b975a3944635bebf5209421a6288